327 related articles for article (PubMed ID: 31211644)
1. Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada.
Moallef S; Nosova E; Milloy MJ; DeBeck K; Fairbairn N; Wood E; Kerr T; Hayashi K
Public Health Rep; 2019; 134(4):423-431. PubMed ID: 31211644
[TBL] [Abstract][Full Text] [Related]
2. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada.
Brar R; Grant C; DeBeck K; Milloy MJ; Fairbairn N; Wood E; Kerr T; Hayashi K
Am J Drug Alcohol Abuse; 2020 Sep; 46(5):625-631. PubMed ID: 32689810
[No Abstract] [Full Text] [Related]
3. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
[TBL] [Abstract][Full Text] [Related]
4. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.
Hayashi K; Milloy MJ; Lysyshyn M; DeBeck K; Nosova E; Wood E; Kerr T
Drug Alcohol Depend; 2018 Feb; 183():1-6. PubMed ID: 29220642
[TBL] [Abstract][Full Text] [Related]
5. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
[TBL] [Abstract][Full Text] [Related]
6. High Prevalence of Self-Reported Exposure to Adulterated Drugs Among People Who Experienced an Opioid Overdose in Canada: A Cohort Study.
Prangnell A; Fairgrieve C; Nosova E; DeBeck K; Milloy MJ; Hayashi K
Subst Use Misuse; 2019; 54(6):980-985. PubMed ID: 30663484
[TBL] [Abstract][Full Text] [Related]
7. Being "hooked up" during a sharp increase in the availability of illicitly manufactured fentanyl: Adaptations of drug using practices among people who use drugs (PWUD) in New York City.
McKnight C; Des Jarlais DC
Int J Drug Policy; 2018 Oct; 60():82-88. PubMed ID: 30176422
[TBL] [Abstract][Full Text] [Related]
8. Elevated prevalence of self-reported unintentional exposure to fentanyl among women who use drugs in a Canadian setting: A cross-sectional analysis.
Mitra S; Boyd J; Wood E; Grant C; Milloy MJ; DeBeck K; Kerr T; Hayashi K
Int J Drug Policy; 2020 Sep; 83():102864. PubMed ID: 32702611
[TBL] [Abstract][Full Text] [Related]
9. Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use.
Stein MD; Kenney SR; Anderson BJ; Bailey GL
J Subst Abuse Treat; 2019 Sep; 104():144-147. PubMed ID: 31370978
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
[TBL] [Abstract][Full Text] [Related]
11. Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting.
Hayashi K; Wood E; Dong H; Buxton JA; Fairbairn N; DeBeck K; Milloy MJ; Kerr T
Drug Alcohol Rev; 2021 Sep; 40(6):964-973. PubMed ID: 33604968
[TBL] [Abstract][Full Text] [Related]
12. Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.
Rouhani S; Park JN; Morales KB; Green TC; Sherman SG
Harm Reduct J; 2019 Jun; 16(1):39. PubMed ID: 31234942
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Nonfatal Overdose During a Public Health Emergency.
Wallace B; Kennedy MC; Kerr T; Pauly B
Subst Use Misuse; 2019; 54(1):39-45. PubMed ID: 30362861
[TBL] [Abstract][Full Text] [Related]
14. Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities.
Morales KB; Park JN; Glick JL; Rouhani S; Green TC; Sherman SG
Drug Alcohol Depend; 2019 Nov; 204():107547. PubMed ID: 31536877
[TBL] [Abstract][Full Text] [Related]
15. Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting.
Fairgrieve C; Nosova E; Milloy MJ; Fairbairn N; DeBeck K; Ahamad K; Wood E; Kerr T; Hayashi K
Subst Abus; 2020; 41(3):323-330. PubMed ID: 32348197
[No Abstract] [Full Text] [Related]
16. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and longitudinal correlates of recent exposure to fentanyl among HIV-positive people who use unregulated drugs during a community-wide overdose crisis.
Moallef S; Nosova E; Nolan S; Fairbairn N; Loh J; Hayashi K; Milloy MJ
AIDS Care; 2021 Dec; 33(12):1560-1568. PubMed ID: 33764814
[TBL] [Abstract][Full Text] [Related]
18. Investigating opioid preference to inform safe supply services: A cross sectional study.
Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
[TBL] [Abstract][Full Text] [Related]
19. Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
Moshkforoush M; DeBeck K; Brar R; Fairbairn N; Cui Z; Milloy MJ; Buxton J; Oldenburger T; McLellan W; Kendall P; Sedgemore K; Wilson D; Kerr T; Hayashi K
Harm Reduct J; 2022 May; 19(1):50. PubMed ID: 35614440
[TBL] [Abstract][Full Text] [Related]
20. Correlates of overdose risk perception among illicit opioid users.
Rowe C; Santos GM; Behar E; Coffin PO
Drug Alcohol Depend; 2016 Feb; 159():234-9. PubMed ID: 26754425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
